HOME > ACADEMIA
ACADEMIA
- Japan Oncology Society Warns of Privately Imported Opdivo, Yervoy
July 19, 2016
- JSGO Will Revise Guidelines to Recommend Bevacizumab in Treatment of Stage IVB/Relapsed Cervical Cancer
July 14, 2016
- Biosimilar Use Should Be Required Under Publicly Funded Systems: JSGM Pres.
July 13, 2016
- Japan Esophageal Society to Recommend 5-FU + Cisplatin as 1st-Line Therapy for Esophageal Cancer in New Guidelines
July 7, 2016
- MHLW Working Group Drafting Guidelines for Development of Cell Therapies for Cerebral Infarction
July 4, 2016
- Accelerate Investigator-Initiated Trials to Promote Academia-Led Drug Discovery: New NCGM Research Center Chief
July 1, 2016
- 865,238 People Diagnosed with Cancer in 2012: NCC
June 30, 2016
- MHLW Study Group Aims to Formulate Guidelines for Treatment of Skeletal Dysplasias in FY2017
June 29, 2016
- Nexium, Takecab Added to Standard Treatments for 1st Eradication of H. Pylori: JSHR Guidelines
June 28, 2016
- PD-1’s “Actual Physiology Remains Unclear”: Discoverer of PD-1
June 21, 2016
- No Increased Mortality Risks Seen in Japanese AD Patients on Antipsychotics: Study
June 17, 2016
- Victoza 1st GLP-1 Agent to Thwart Cardiovascular Events; Will It Catch on?
June 15, 2016
- Academic Societies Drafting Guidelines for Clinically Evaluating Efficacy of Drugs for AMR Infectious Diseases
June 15, 2016
- As Spate of Melanoma Drugs Debut, Physicians Still Exploring Best Drug Choices, Combos
June 14, 2016
- Gilead’s 2 Hep C Treatments Highly Effective in Actual Clinical Practice: Multicenter Studies Results
May 24, 2016
- Diabetes Society Calls for Careful Administration of SGLT-2 Inhibitors to Geriatric Syndrome Patients, Aged 75 or Over
May 19, 2016
- MHLW Study Group Drafting Guidelines for Assessing Cost-Effectiveness of Vaccines Proposed for Inclusion in Public Vaccination Programs
May 16, 2016
- Use Patient Registries for Orphan, Intractable Diseases First: MHLW Study Group Chief
May 9, 2016
- At Least 20% of Patients Taking Xeljanz against Guidelines: Interim Analysis of PMS
April 26, 2016
- AMED Study Team Drafting First Guidelines for Diagnosis and Treatment of Post-Stroke Epilepsy
April 21, 2016
ページ
In the complex landscape of the Japanese pharmaceutical market, the “status quo” is often the safest harbor. But for leaders like Kennet Brysting, former president of Gilead Japan, the status quo is the most dangerous place to stay.Innovation in Japan…
